Medicare Enrolled
Dr. Burhan Mohamedali, MD
Cardiovascular Disease · San Diego, CA
Practice pattern: Cardiac & Cardiac
— Practice combining cardiac and cardiac services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mohamedali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mohamedali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mohamedali
Dr. Burhan Mohamedali is a cardiovascular disease specialist in San Diego, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mohamedali performed 2,668 Medicare services across 1,829 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mohamedali received a total of $150,003 from 53 pharmaceutical and/or device companies across 1454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mohamedali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 39% volume in CA
$150,003 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,668
Medicare services
Top 39% in CA for cardiovascular disease
1,829
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~148 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
713 | $99 | $280 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
471 | $160 | $461 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
428 | $12 | $55 |
| Heart muscle strain imaging | 373 | $33 | $95 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
210 | $98 | $280 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
88 | $43 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $143 | $477 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
53 | $21 | $60 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
53 | $773 | $1,955 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
46 | $106 | $1,620 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $130 | $366 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $59 | $194 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $63 | $239 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
22 | $402 | $1,251 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
22 | $62 | $275 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
22 | $1 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.5% high complexity
20.7% medium
60.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$150,003
Total received (2018-2024)
Avg $21,429/year across 7 years
Top 5% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,454
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114,011 (76.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,908 (15.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,084 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19,905
2023
$33,191
2022
$8,700
2021
$21,630
2020
$11,925
2019
$25,024
2018
$29,628
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Actelion Pharmaceuticals US, Inc.
$13,458
AstraZeneca Pharmaceuticals LP
$2,326
Bayer Healthcare Pharmaceuticals Inc.
$1,032
Abbott Laboratories
$393
Edwards Lifesciences Corporation
$303
HEARTFLOW, INC.
$282
SCPHARMACEUTICALS INC.
$236
Boston Scientific Corporation
$194
Alnylam Pharmaceuticals Inc.
$178
Novartis Pharmaceuticals Corporation
$177
Merck Sharp & Dohme LLC
$173
Lexicon Pharmaceuticals, Inc.
$158
Kestra Medical Technology Services, Inc.
$137
PFIZER INC.
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
E.R. Squibb & Sons, L.L.C.
$113
BIOTRONIK INC.
$104
Cleerly, Inc.
$83
Kiniksa Pharmaceuticals International, plc
$83
Daiichi Sankyo Inc.
$72
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$52
CVRx, Inc.
$40
Janssen Pharmaceuticals, Inc
$25
ShockWave Medical, Inc
$24
Top 3 companies account for 84.5% of 2024 payments
All-time payments by company (2018-2024) ›
Actelion Pharmaceuticals US, Inc.
$31,553
Boston Scientific Corporation
$27,991
Novartis Pharmaceuticals Corporation
$25,761
AstraZeneca Pharmaceuticals LP
$23,915
Abbott Laboratories
$16,071
BOSTON SCIENTIFIC CORPORATION
$7,014
Medtronic Vascular, Inc.
$2,077
PFIZER INC.
$1,685
Edwards Lifesciences Corporation
$1,528
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,512
Janssen Pharmaceuticals, Inc
$1,411
Bayer Healthcare Pharmaceuticals Inc.
$1,301
Impulse Dynamics (USA) Inc.
$889
E.R. Squibb & Sons, L.L.C.
$688
Merck Sharp & Dohme LLC
$556
Medtronic, Inc.
$500
Astellas Pharma US Inc
$486
CVRx, Inc.
$414
Boehringer Ingelheim Pharmaceuticals, Inc.
$412
Alnylam Pharmaceuticals Inc.
$365
Shockwave Medical, Inc
$319
SCPHARMACEUTICALS INC.
$294
ABIOMED
$283
HEARTFLOW, INC.
$282
Amgen Inc.
$240
BIOTRONIK INC.
$236
Lexicon Pharmaceuticals, Inc.
$218
Kestra Medical Technology Services, Inc.
$201
Merck Sharp & Dohme Corporation
$172
Daiichi Sankyo Inc.
$153
Bayer HealthCare Pharmaceuticals Inc.
$148
SANOFI-AVENTIS U.S. LLC
$131
ShockWave Medical, Inc
$116
Biosense Webster, Inc.
$114
Kiniksa Pharmaceuticals, Ltd.
$104
Amarin Pharma Inc.
$98
Gilead Sciences, Inc.
$93
Cleerly, Inc.
$83
Kiniksa Pharmaceuticals International, plc
$83
ATRICURE, INC.
$70
Philips Electronics North America Corporation
$68
Novo Nordisk Inc
$53
Tactile Systems Technology Inc
$41
CARDIVA MEDICAL, INC.
$41
Esperion Therapeutics, Inc.
$40
HeartFlow, Inc.
$38
iRhythm Technologies, Inc.
$31
PORTOLA PHARMACEUTICALS, LLC
$27
Otsuka America Pharmaceutical, Inc.
$23
United Therapeutics Corporation
$22
Relypsa, Inc.
$22
Nevro Corp.
$16
Itamar Medical Inc
$13
Top 3 companies account for 56.9% of all-time payments
Associated products mentioned in payments ›
(6582) Visions 035 · AMVUTTRA · ANDEXXA · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · AZURE XT DR MRI SURESCAN · Accent Pacemaker · Adempas · Allure Quadra RF CRT Pacemaker · Amplia MRI · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CONFIRM RX · CRESEMBA · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · Carto 3 · Circulatory Support · Claria MRI · Cleerly Ischemia · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · ELIQUIS · EMBLEM · ENSITE · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLEXITOUCH · FORTIFY ASSURA · FUROSCIX · GALLANT · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · HeartMate · HeartMate 3 Left Ventricular Assist Device · HeartWare HVAD · INJECTAFER · Impella · Inpefa · JARDIANCE · JOT DX · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · MYLUX · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NAVITOR · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · ORENITRAM · Optimizer · Optimizer Smart System · Ozempic · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · Pacemakers · Plexa ProMRI · Quadra Assura CRT Defibrillator · RESONATE · Repatha · Resolute · Reveal LINQ · Rivacor 7 DR-T · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Senza · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Trilogy 100 · UPTRAVI · VARITHENA · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · Vascular Closure Device · Veltassa · Verquvo · VersaCross Access Solution · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · WatchPAT · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
239
Per 100K population
7.3
County median income
$102,285
Nearest hospital
UC SAN DIEGO HEALTH HILLCREST - HILLCREST MED CTR
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mohamedali is a cardiac & cardiac specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mohamedali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mohamedali performed 713 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mohamedali receive payments from pharmaceutical companies?
Yes. Dr. Mohamedali received a total of $150,003 from 53 companies across 1,454 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mohamedali's costs compare to other cardiologists in San Diego?
Dr. Mohamedali's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mohamedali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Diego
Browse cardiologists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology